QUARTERLY FOCUS ISSUE: HEART RHYTHM DISORDER: CLINICAL RESEARCH: ACUTE MYOCARDIAL INFARCTION
Metabolic Syndrome and Risk of Acute Myocardial InfarctionA Case-Control Study of 26,903 Subjects From 52 Countries
Andrew Mente, PhD*, ,
Salim Yusuf, MBBS, DPhil*, ,
Shofiqul Islam, MS*,
Matthew J. McQueen, MBChB, PhD*, ,
Supachai Tanomsup, MD ,
Churchill L. Onen, MD||,
Sumathy Rangarajan, MS*,
Hertzel C. Gerstein, MD, MS*, ,
Sonia S. Anand, MD, PhD*, ,* for the INTERHEART Investigators
* Population Health Research Institute, Hamilton Health Sciences, McMaster University, Hamilton, Ontario, Canada
Department of Medicine and Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada
Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada
Division of Cardiology, Ramathibodi Hospital, Bangkok, Thailand
|| Center for Chronic Diseases, Gaborone Private Hospital, Gaborone, Botswana
Manuscript received September 28, 2009;
revised manuscript received December 14, 2009,
accepted December 17, 2009.
* Reprint requests and correspondence: Dr. Sonia S. Anand, David Braley Cardiac, Vascular and Stroke Research Institute, Hamilton General Hospital Campus, 237 Barton Street East, Room C3-102, Hamilton, Ontario L8L 2X2, Canada (Email: anands{at}mcmaster.ca).
Objectives: This study examines the risk of acute myocardial infarction (MI) conferred by the metabolic syndrome (MS) and its individual factors in multiple ethnic populations.
Background: The risk of the MS on MI has not been well characterized, especially in multiple ethnic groups.
Methods: Participants in the INTERHEART study (n = 26,903) involving 52 countries were classified using the World Health Organization (WHO) and International Diabetes Federation (IDF) criteria for MS, and their odds ratios (ORs) for MI were compared with the individual MS component factors.
Results: The MS is associated with an increased risk of MI, both using the WHO (OR: 2.69; 95% confidence interval [CI]: 2.45 to 2.95) and IDF (OR: 2.20; 95% CI: 2.03 to 2.38) definitions, with corresponding population attributable risks of 14.5% (95% CI: 12.7% to 16.3%) and 16.8% (95% CI: 14.8% to 18.8%), respectively. The associations are directionally similar across all regions and ethnic groups. Using the WHO definition, the association with MI by the MS is similar to that of diabetes mellitus (OR: 2.72; 95% CI: 2.53 to 2.92) and hypertension (OR: 2.60; 95% CI: 2.46 to 2.76), and significantly stronger than that of the other component risk factors. The clustering of 3 risk factors with subthreshold values is associated with an increased risk of MI (OR: 1.50; 95% CI: 1.24 to 1.81) compared with having component factors with "normal" values. The IDF definition showed similar results.
Conclusions: In this large-scale, multi-ethnic, international investigation, the risk of MS on MI is generally comparable to that conferred by some, but not all, of its component risk factors. The characterization of risk factors, especially continuous variables, as dichotomous will underestimate risk and decrease the magnitude of association between MS and MI.
Key Words: myocardial infarction metabolic syndrome diabetes mellitus ethnicity epidemiology
|
Abbreviations and Acronyms
| | Apo = apolipoprotein | | CI = confidence interval | | Hb = hemoglobin | | HDL = high-density lipoprotein | | IDF = International Diabetes Federation | | MI = myocardial infarction | | MS = metabolic syndrome | | OR = odds ratio | | PAR = population attributable risk | | WHO = World Health Organization |
|
Related Articles
-
The Concept of the Metabolic Syndrome: Is It Dead Yet?
- Ajay K. Gupta and Neil R. Poulter
J. Am. Coll. Cardiol. 2010 56: 1355-1356.
[Full Text]
[PDF]
-
Inside This Issue
J. Am. Coll. Cardiol. 2010 55: A27.
[Full Text]
[PDF]
This article has been cited by other articles:

|
 |

|
 |
 
S. W. Oh, S. H. Baek, Y. C. Kim, H. S. Goo, H. J. Chin, K. Y. Na, D. W. Chae, and S. Kim
Higher hemoglobin level is associated with subtle declines in renal function and presence of cardiorenal risk factors in early CKD stages
Nephrol. Dial. Transplant.,
January 1, 2012;
27(1):
267 - 275.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. J. Joseph, R. L. Prigeon, J. B. Blumenthal, A. S. Ryan, and A. P. Goldberg
Weight Loss and Low-Intensity Exercise for the Treatment of Metabolic Syndrome in Obese Postmenopausal Women
J Gerontol A Biol Sci Med Sci,
September 1, 2011;
66A(9):
1022 - 1029.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Sanz and V. Fuster
The Year in Atherothrombosis
J. Am. Coll. Cardiol.,
August 16, 2011;
58(8):
779 - 791.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. J. Nicholls
Insights From a Virtual World
J. Am. Coll. Cardiol. Intv.,
May 1, 2011;
4(5):
511 - 512.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. K. Gupta and N. R. Poulter
The Concept of the Metabolic Syndrome: Is It Dead Yet?
J. Am. Coll. Cardiol.,
October 12, 2010;
56(16):
1355 - 1356.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Mente and S. Anand
Reply
J. Am. Coll. Cardiol.,
October 12, 2010;
56(16):
1356 - 1356.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Metabolic Syndrome and Risk for Myocardial Infarction
Journal Watch (General),
June 22, 2010;
2010(622):
2 - 2.
[Full Text]
|
 |
|
|